Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × Cytarabine × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 54 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Myelodysplastic Syndromes 13 Burkitt Lymphoma 13 Leukemia, Biphenotypic, Acute 11 Leukemia 7 Recurrence 6 Lymphoma, Mantle-Cell 6 Leukemia, Myelomonocytic, Chronic 6 Lymphoma 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Myeloproliferative Disorders 4 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Large B-Cell, Diffuse 3 Neoplasm, Residual 2 Lymphoma, B-Cell 2 Leukemia, Myelomonocytic, Juvenile 2 Hematologic Neoplasms 2 Blastic Plasmacytoid Dendritic Cell Neoplasm 2 Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Sarcoma, Myeloid 1 Rasmussen subacute encephalitis 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Philadelphia Chromosome 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic-Myeloproliferative Diseases 1

Interventions

pembrolizumab 2 durvalumab 2 Standard of Care 2 Paclitaxel 2 Oxaliplatin 2 Irinotecan 2 Chemoradiotherapy 2 Carboplatin 2 Capecitabine 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 talazoparib 1 sarilumab 1 relugolix 1 regorafenib 1 pexidartinib 1 pertuzumab 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 enzalutamide 1 dostarlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡